Risk factors of early thyroid dysfunction after definitive radiotherapy in nasopharyngeal carcinoma patients

被引:7
作者
Lian, Chen-Lu [1 ,2 ]
Zhuo, Ren-Gong [3 ]
Zhou, Rui [1 ]
Yu, Yi-Feng [1 ]
Zhou, Ping [1 ]
Lin, Qin [1 ]
Wu, San-Gang [1 ,4 ]
机构
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Radiat Oncol,Xiamen Key Lab Radiat On, Xiamen, Peoples R China
[2] Fudan Univ, Dept Radiat Oncol, Xiamen branch, Shanghai Canc Ctr, Xiamen, Peoples R China
[3] Xiamen Univ, Sch Med, Xiamen Key Lab Chiral Drugs, Xiamen, Peoples R China
[4] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Radiat Oncol,Xiamen Key Lab Radiat On, Xiamen 361003, Peoples R China
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2023年 / 45卷 / 09期
关键词
hypothyroidism; IMRT; nasopharyngeal carcinoma; risk factors; RADIATION-INDUCED HYPOTHYROIDISM; DOSIMETRIC PREDICTORS; HEAD; THERAPY; CANCER; IRRADIATION;
D O I
10.1002/hed.27448
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundTo explore the patterns and risk factors of early thyroid dysfunction in nasopharyngeal carcinoma (NPC) patients within 1 year after intensity-modulated radiation therapy (IMRT). MethodsPatients with NPC who received definitive IMRT between April 2016 and April 2020 were included. All patients had normal thyroid function before definitive IMRT. The chi-square test, Student's T-test, Mann-Whitney U test, Kaplan-Meier method, receiver operating characteristics curve, and Cox proportional hazard analysis were used for statistical analysis. ResultsA total of 132 NPC patients were identified. Of these patients, 56 (42.4%) had hypothyroidism and 17 (12.9%) had hyperthyroidism. The median time to hypothyroidism and hyperthyroidism was 9 months (range, 1-12 months) and 1 month (range, 1-6 months) after definitive IMRT, respectively. In patients with hypothyroidism, 41 (73.2%) had subclinical hypothyroidism and 15 (26.8%) had clinical hypothyroidism. In those with hyperthyroidism, 12 patients (70.6%) had subclinical hyperthyroidism, and five patients (29.4%) had clinical hyperthyroidism. Age, clinical stage, thyroid volume, and V45 were independent risk factors for early radiation-induced hypothyroidism within 1 year after IMRT. Patients aged <47 years, stage III/IV disease, or pre-irradiation thyroid volume < 14 cm(3) had higher risks of developing hypothyroidism. ConclusionPrimary subclinical hypothyroidism was the most common subtype of early thyroid dysfunction in NPC patients within 1 year after IMRT. Age, clinical stage, thyroid volume, and V45 were independent risk factors for early radiation-induced hypothyroidism in NPC patients.
引用
收藏
页码:2344 / 2354
页数:11
相关论文
共 31 条
[1]   Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: A retrospective analysis of seventy-three patients [J].
Alterio, Daniela ;
Jereczek-Fossa, Barbara Alicja ;
Franchi, Benedetta ;
D'Onofrio, Alberto ;
Piazzi, Valeria ;
Rondi, Elena ;
Ciocca, Mario ;
Gibelli, Bianca ;
Grosso, Enrica ;
Tradati, Nicoletta ;
Mariani, Luigi ;
Boboc, Genoveva Ionela ;
Orecchia, Roberto .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01) :144-150
[2]  
[Anonymous], 2017, AJCC Cancer Staging Manual, V8
[3]  
[Anonymous], 2021, Head and neck cancer
[4]   Normal Tissue Complication Probability Modeling of Radiation-Induced Hypothyroidism After Head-and-Neck Radiation Therapy [J].
Bakhshandeh, Mohsen ;
Hashemi, Bijan ;
Mahdavi, Seied Rabi Mehdi ;
Nikoofar, Alireza ;
Vasheghani, Maryam ;
Kazemnejad, Anoshirvan .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (02) :514-521
[5]   Nasopharyngeal carcinoma [J].
Chen, Yu-Pei ;
Chan, Anthony T. C. ;
Quynh-Thu Le ;
Blanchard, Pierre ;
Sun, Ying ;
Ma, Jun .
LANCET, 2019, 394 (10192) :64-80
[6]   HYPOTHYROIDISM AS A CONSEQUENCE OF INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT TAXANE-BASED CHEMOTHERAPY FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER [J].
Diaz, Roberto ;
Jaboin, Jerry J. ;
Morales-Paliza, Manuel ;
Koehler, Elizabeth ;
Phillips, John G. ;
Stinson, Scott ;
Gilbert, Jill ;
Chung, Christine H. ;
Murphy, Barbara A. ;
Yarbrough, Wendell G. ;
Murphy, Patrick B. ;
Shyr, Yu ;
Cmelak, Anthony J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02) :468-476
[7]   Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study [J].
Fan, Chao-Yueh ;
Lin, Chun-Shu ;
Chao, Hsing-Lung ;
Huang, Wen-Yen ;
Su, Yu-Fu ;
Lin, Kuen-Tze ;
Tsai, I-Ju ;
Kao, Chia-Hung .
RADIOTHERAPY AND ONCOLOGY, 2017, 123 (03) :394-400
[8]   Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study [J].
Huang, Cheng-Long ;
Tan, Hong-Wen ;
Guo, Rui ;
Zhang, Yuan ;
Peng, Hao ;
Peng, Liang ;
Lin, Ai-Hua ;
Mao, Yan-Ping ;
Sun, Ying ;
Ma, Jun ;
Tang, Ling-Long .
CANCER MEDICINE, 2019, 8 (16) :6887-6893
[9]   Radiotherapy-induced thyroid disorders [J].
Jereczek-Fossa, BA ;
Alterio, D ;
Jassem, J ;
Gibelli, B ;
Tradati, N ;
Orecchia, R .
CANCER TREATMENT REVIEWS, 2004, 30 (04) :369-384
[10]   Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma [J].
Kamal, Mona ;
Peeler, Christopher Ryan ;
Yepes, Pablo ;
Mohamed, Abdallah S. R. ;
Blanchard, Pierre ;
Frank, Steven ;
Chen, Lei ;
Jethanandani, Amit ;
Kuruvilla, Rohit ;
Greiner, Benjamin ;
Harp, Jared ;
Granberry, Robin ;
Mehta, Vivek ;
Rock, Crosby ;
Hutcheson, Katherine ;
Cardenas, Carlos ;
Gunn, G. Brandon ;
Fuller, Clifton ;
Mirkovic, Dragan .
ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (01) :111-119